Cargando…
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses
Dendritic cells (DCs) hold promise for anti-cancer immunotherapy. However, clinically, their efficiency is limited and novel strategies to improve DC-mediated anti-tumor responses are needed. Human DCs display high content of sialic acids, which inhibits their maturation and co-stimulation capacity....
Autores principales: | Silva, Mariana, Silva, Zélia, Marques, Graça, Ferro, Tiago, Gonçalves, Márcia, Monteiro, Mauro, van Vliet, Sandra J., Mohr, Elodie, Lino, Andreia C., Fernandes, Alexandra R., Lima, Flávia A., van Kooyk, Yvette, Matos, Teresa, Tadokoro, Carlos E., Videira, Paula A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173042/ https://www.ncbi.nlm.nih.gov/pubmed/27203391 http://dx.doi.org/10.18632/oncotarget.9419 |
Ejemplares similares
-
Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods
por: Marques, Graça S, et al.
Publicado: (2018) -
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
por: Lübbers, Joyce, et al.
Publicado: (2018) -
Dendritic Cells: A Spot on Sialic Acid
por: Crespo, Hélio J., et al.
Publicado: (2013) -
MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
por: Silva, Zélia, et al.
Publicado: (2020) -
α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programming
por: Lübbers, Joyce, et al.
Publicado: (2021)